Clinical use of dexmedetomidine in monitored anesthesia care

Korean Journal of Anesthesiology

Volumn 61, Issue 6, 2011, Pages 451-452

  Lee, Soo Kyung ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; CLONIDINE; DEXMEDETOMIDINE; FENTANYL; HYPNOTIC AGENT; KETAMINE; MIDAZOLAM; PLACEBO; PROPOFOL; REMIFENTANIL; SEDATIVE AGENT;

ANALGESIA; ANESTHESIA; BLOOD PRESSURE; BRADYCARDIA; CATECHOLAMINE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SPECIFICITY; DRUG USE; DRUG WITHDRAWAL; EDITORIAL; HEART CATHETERIZATION; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; LOADING DRUG DOSE; MEAN ARTERIAL PRESSURE; PATIENT CARE; PATIENT MONITORING; PULMONARY HYPERTENSION; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; TACHYCARDIA; TREATMENT WITHDRAWAL; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 84855301452     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2011.61.6.451     Document Type: Editorial

References (13)

1. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-8.
2. Candiotti KA, Bergese SD, Bokesch PM, Feldman MA, Wisemandle W, Bekker AY, et al. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg 2010; 110: 47-56.
3. Cooper L, Candiotti K, Gallagher C, Grenier E, Arheart KL, Barron ME. A randomized, controlled trial on dexmedetomidine for providing adequate sedation and hemodynamic control for awake, diagnostic transesophageal echocardiography. J Cardiothorac Vasc Anesth 2011; 25: 233-7.
4. Kaygusuz K, Gokce G, Gursoy S, Ayan S, Mimaroglu C, Gultekin Y. A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: a randomized controlled trial. Anesth Analg 2008; 106: 114-9.
5. Na HS, Song IA, Park HS, Hwang JW, Do SH, Kim CS. Dexmedetomidine is effective for monitored anesthesia care in outpatients undergoing cataract surgery. Korean J Anesthesiol 2011; 61: 453-9.
6. Muller S, Borowics SM, Fortis EA, Stefani LC, Soares G, Maguilnik I, et al. Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP. Gastrointest Endosc 2008; 67: 651-9.
7. Tosun Z, Akin A, Guler G, Esmaoglu A, Boyaci A. Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatrics undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2006; 20: 515-9.
8. Kallio A, Scheinin M, Koulu M, Ponkilainen R, Ruskoaho H, Viinamäki O, et al. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989; 46: 33-42.
9. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-42.
10. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94.
11. Gerlach AT, Murphy CV. Dexmedetomidine-associated bradycardia progression to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 2009; 29: 1492.
12. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 2004; 16: 124-6.
13. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-42.